Compounders Research Compare

Achieve Life Sciences, Inc.(ACHV)

Biotechnology · Bothell, WA

$7.15+0.14 (+2.03%)

Delayed quote: Oct 6, 2026, 9:35 AM EDT

About Achieve Life Sciences, Inc.

Achieve Life Sciences, Inc. operates as a clinical-stage pharmaceutical firm, concentrating on the development and market introduction of cytisinicline. This compound is aimed at assisting with smoking cessation and nicotine dependence, with commercial activities spanning Canada, the United States, and the United Kingdom. Cytisinicline is a naturally occurring alkaloid, which functions by engaging with nicotine receptors in the brain to lessen the intensity of nicotine withdrawal symptoms. The company holds licensing agreements with Sopharma AD and the University of Bristol. Its corporate headquarters are located in Vancouver, Canada.

Bothell, WA

28 employees

www.achievelifesciences.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Andrew D. Goldberg

View full financials

Earnings Yield: N/A

Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The earnings yield is N/A as of 2026-10-06T13:35:18.936Z.

Stored calculation inputs

Calculation as of: 2026-10-06T13:35:18.936Z.

Quote observation: 2026-10-06T13:35:02.000Z. Amounts in USD. The price header may show a later quote.

Unrounded diluted TTM EPS · period ending 2026-06-30: -1.55
Quote price: 7.1523

FMP input reference: c295c1623f78bdf77a886cf07ea1e6d336f06da24b8c95eb76ef4971c7c9c79e

P/E Ratio|FCF Yield|Dividend Yield|All Metrics

ACHV Earnings Yield Metrics

EARNINGS YIELD

N/A

ACHV Competitors' Earnings Yield

Achieve Life Sciences, Inc.

Current

Market Cap

$734.25M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Anteris Technologies Global Corp.

Market Cap

$731.67M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Candel Therapeutics, Inc.

Market Cap

$749.92M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Avalo Therapeutics, Inc.

Market Cap

$754.84M

Earnings Yield

N/A

TTM Avg

0.35%

3Y Avg

0.35%

5Y Avg

0.35%

Collegium Pharmaceutical, Inc.

Market Cap

$710.14M

Earnings Yield

5.66%

TTM Avg

4.56%

3Y Avg

4.80%

5Y Avg

6.03%

Helus Pharma Inc.

Market Cap

$696.39M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Faeth Therapeutics, Inc.

Market Cap

$693.14M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Geron Corporation

Market Cap

$776.30M

Earnings Yield

N/A

TTM Avg

0.17%

3Y Avg

0.17%

5Y Avg

0.17%

Design Therapeutics, Inc.

Market Cap

$778.67M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Annexon, Inc.

Market Cap

$681.19M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EARNINGS YIELD	TTM	3Y	5Y
Achieve Life Sciences, Inc. (ACHV)	$734.25M	N/A	N/A	N/A	N/A
Anteris Technologies Global Corp. (AVR)vs ›	$731.67M	N/A	N/A	N/A	N/A
Candel Therapeutics, Inc. (CADL)vs ›	$749.92M	N/A	N/A	N/A	N/A
Avalo Therapeutics, Inc. (AVTX)vs ›	$754.84M	N/A	0.35%	0.35%	0.35%
Collegium Pharmaceutical, Inc. (COLL)vs ›	$710.14M	5.66%	4.56%	4.80%	6.03%
Helus Pharma Inc. (HELP)vs ›	$696.39M	N/A	N/A	N/A	N/A
Faeth Therapeutics, Inc. (FTH)vs ›	$693.14M	N/A	N/A	N/A	N/A
Geron Corporation (GERN)vs ›	$776.30M	N/A	0.17%	0.17%	0.17%
Design Therapeutics, Inc. (DSGN)vs ›	$778.67M	N/A	N/A	N/A	N/A
Annexon, Inc. (ANNX)vs ›	$681.19M	N/A	N/A	N/A	N/A

Earnings Yield vs P/E Ratio

Earnings Yield

N/A

EPS ÷ Price

P/E Ratio

N/A

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

It expresses earnings relative to share price as a percentage
It can be compared with FCF yield and dividend yield
It can be compared with bond yields because both are percentages
It is mathematically the inverse of the P/E ratio

Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

P/E Ratio FCF Yield Dividend Yield All Metrics